Non-classical clinical presentation of ICI-BP

NIAID Data Ecosystem2026-05-01 收录

不良药物反应

免疫治疗毒性识别

数据链接：

https://data.mendeley.com/datasets/w3y584hsw4 数据链接链接失效反馈

官方服务：

资源简介：

The pictures of non-classical clinical presentation of Immune checkpoint inhibitor-induced bullous pemphigoid.

创建时间：

2023-06-15

Trends in the use of sodium-glucose cotransporter-2 inhibitors and characteristics of adverse event reporting in patients with heart failure in Japan: reports from the medical administration database and the adverse event reporting database

心力衰竭治疗

不良药物反应

Heart failure (HF) is a global health issue with a high prevalence in aging populations. Sodium-glucose cotransporter-2 (SGLT2) inhibitors reduce HF-related hospitalizations and mortality; however, th

NIAID Data Ecosystem50

Variables associated with the occurrence of ADR in patients hospitalized in a general hospital in univariate and multivariate analysis by conditional logistic regression.

不良药物反应

临床风险评估

Variables associated with the occurrence of ADR in patients hospitalized in a general hospital in univariate and multivariate analysis by conditional logistic regression.

Figshare2020-12-11 更新40

Factors associated with incidence of DRMs.

不良药物反应

临床风险评估

Factors associated with incidence of DRMs.

Figshare2016-02-22 更新30

Table of adverse drug reactions.

药物安全监测

不良药物反应

Table of adverse drug reactions.

NIAID Data Ecosystem50

Phase II study of bevacizumab and irinotecan plus alternate-day S-1 as second-line therapy in patients with metastatic colorectal cancer.

转移性结直肠癌化疗

不良药物反应

Interventions: Alternate-day S-1 (80mg/m2; day 2,4,6...14) combined with irinotecan (150mg/m2; day 1) and bevacizumab (5.0 mg/kg; day 1) Primary outcome(s): Incidence of grade 3 or 4 diarrhea Study De

NIAID Data Ecosystem40

Non-classical clinical presentation of ICI-BP

资源简介：

相关数据集